Pharma Sector Overview
| Sun Pharmaceutical Industries Ltd. | 8.93% | 8.42% | 10.80% | 34.43% | 30.18% | 30.14% | 2.36% | 14.29% | 21.58% | 20.85% | 4,06,710.43 Cr |
| Dr. Reddy's Laboratories Ltd. | 9.83% | 16.54% | 14.86% | 26.51% | 29.61% | 27.09% | 7.29% | 1.27% | 15.14% | 17.54% | 1,03,572.55 Cr |
| Cipla Ltd. | 7.64% | 6.88% | 133.05% | 28.51% | 28.92% | 17.97% | 3.72% | 27.89% | 17.83% | 19.13% | 1,07,413.06 Cr |
| Lupin Ltd. | 24.23% | 13.48% | 11.45% | 34.50% | 24.13% | 11.23% | 73.05% | 71.11% | 21.07% | 14.56% | 99,243.53 Cr |
| Biocon Ltd. | 19.64% | 3.43% | 23.09% | 21.06% | 29.93% | 27.34% | 607.69% | -1.05% | 3.09% | 9.37% | 43,869.92 Cr |
| Divi's Laboratories Ltd. | 16.12% | 19.31% | -52.90% | 38.05% | 35.47% | 34.09% | 35.26% | 36.93% | 25.38% | 23.41% | 1,59,931.8 Cr |
| Piramal Pharma Ltd. | -8.83% | 11.99% | 140.74% | 11.70% | 18.06% | 13.32% | -541.18% | 392.86% | -4.85% | 1.00% | 21,046.28 Cr |
| Emcure Pharmaceuticals Ltd. | 13.38% | N/A | 10.48% | 21.09% | 19.26% | 19.43% | 23.80% | N/A | 11.07% | 8.96% | 28,719.94 Cr |
| Jubilant Pharmova Ltd. | 12.22% | 7.93% | 5.68% | 17.27% | 26.94% | 14.81% | 17.31% | 988.09% | 6.10% | 11.56% | 14,934.98 Cr |
| Alembic Pharmaceuticals Ltd. | 15.91% | 7.12% | 132.54% | 16.96% | 16.15% | 15.15% | 20.67% | -5.27% | 9.62% | 8.72% | 15,678.85 Cr |
| Laurus Labs Ltd. | 35.12% | 10.18% | 124.09% | 26.06% | 20.42% | 23.84% | 875.68% | 123.15% | 11.76% | 6.45% | 51,258.6 Cr |
| Ajanta Pharma Ltd. | 14.08% | 10.44% | 140.51% | 28.60% | 29.13% | 19.61% | 20.61% | 13.48% | 19.22% | 19.80% | 35,633.65 Cr |
| JB Chemicals & Pharmaceuticals Ltd. | 8.42% | 12.45% | -45.53% | 29.95% | 27.31% | 24.62% | 18.24% | 19.04% | 19.16% | 16.83% | 28,792.46 Cr |
| Glaxosmithkline Pharmaceuticals Ltd. | -3.05% | 8.56% | -51.46% | 38.22% | 35.55% | 27.00% | 2.73% | 57.22% | 26.28% | 24.74% | 42,080.45 Cr |
| Eris Lifesciences Ltd. | 6.91% | 44.02% | 29.03% | 36.76% | 35.79% | 32.97% | 31.05% | -10.31% | 16.97% | 12.95% | 19,484.93 Cr |
| Dishman Carbogen Amcis Ltd. | -17.29% | 3.66% | 133.11% | 24.06% | 16.76% | 15.01% | 97.16% | 102.15% | 10.00% | 0.12% | 3,149.61 Cr |
| Marksans Pharma Ltd. | 12.23% | 20.46% | 20.72% | 23.05% | 22.84% | 21.20% | 1.88% | 21.39% | 13.76% | 14.59% | 8,037.32 Cr |
| Aarti Drugs Ltd. | 9.10% | -5.60% | -54.22% | 12.92% | 12.71% | 12.39% | 29.24% | -1.13% | 6.92% | 7.04% | 3,419.43 Cr |
| Aarti Pharmalabs Ltd. | -8.67% | 14.17% | -43.93% | 17.72% | 22.43% | 20.41% | -48.92% | 25.62% | 6.67% | 12.88% | 7,040.5 Cr |
| IOL Chemicals And Pharmaceuticals Ltd. | 7.95% | -2.51% | 111.94% | 11.27% | 10.81% | 11.45% | 56.92% | -24.89% | 5.28% | 4.86% | 2,218.78 Cr |
| Caplin Point Laboratories Ltd. | 10.54% | 14.37% | 148.05% | 41.11% | 38.37% | 36.25% | 18.00% | 17.25% | 30.00% | 27.93% | 13,877.46 Cr |
| Hikal Ltd. | -29.68% | 4.21% | -1.44% | 2.86% | 17.93% | 15.33% | -291.22% | 30.50% | -10.96% | 4.88% | 2,213.5 Cr |
| Morepen Laboratories Ltd. | -5.97% | 7.17% | -51.07% | 21.09% | 10.62% | 8.96% | 15.38% | 17.02% | 9.93% | 6.51% | 2,010.44 Cr |
| Sai Life Sciences Ltd. | 35.88% | 15.66% | 24.91% | 29.98% | 26.11% | 21.31% | 80.63% | 93.22% | 15.60% | 10.04% | 17,711.02 Cr |
| Nectar Lifesciences Ltd. | -98.67% | -0.74% | 0.08% | -4.60% | -1.29% | 4.68% | -3240.00% | -2404.55% | -5.00% | -5.95% | 301.63 Cr |
| Viyash Scientific Ltd. | 15.01% | 13.26% | 3.17% | 12.84% | 10.73% | 5.81% | 436.36% | 161.11% | 4.62% | 2.08% | N/A |
| Neuland Laboratories Ltd. | 65.44% | -5.24% | -46.25% | 30.60% | 33.62% | 25.80% | 194.88% | -13.32% | 18.83% | 17.61% | 16,717.36 Cr |
| Onesource Specialty Pharma Ltd. | 452.76% | 740.42% | 124.22% | 29.15% | 18.15% | -141.16% | 123.65% | 98.27% | 2.79% | -1.20% | 12,815.69 Cr |
| Shilpa Medicare Ltd. | 7.61% | 11.71% | -51.75% | 29.71% | 21.98% | 19.93% | 144.57% | 119.07% | 11.91% | 6.09% | 3,089.21 Cr |
| Solara Active Pharma Sciences Ltd. | -9.63% | -0.40% | 116.31% | 11.23% | 16.72% | 6.86% | -192.91% | 100.09% | -3.22% | 0.04% | 2,262.58 Cr |
| Innova Captab Ltd. | 19.54% | 15.02% | 15.82% | 14.74% | 15.94% | 13.57% | -15.36% | 20.10% | 7.80% | 10.31% | 4,049.52 Cr |
| Cohance Lifesciences Ltd. | 115.57% | 13.91% | -55.07% | 24.58% | 36.22% | 42.32% | -46.56% | -10.85% | 11.95% | 22.11% | N/A |
| Acutaas Chemicals Ltd. | 24.10% | 40.34% | -42.15% | 34.34% | 24.73% | 21.42% | 88.06% | 239.79% | 23.47% | 15.93% | N/A |
| Bliss GVS Pharma Ltd. | 12.27% | 5.13% | -52.33% | 21.25% | 20.15% | 20.47% | 11.69% | 10.93% | 11.70% | 11.15% | 1,930.38 Cr |
| Advanced Enzyme Technologies Ltd. | 26.31% | 2.09% | 6.36% | 38.12% | 35.72% | 36.16% | 31.63% | -1.68% | 24.24% | 21.04% | 3,216.02 Cr |
| Kopran Ltd. | -22.20% | 2.44% | -49.10% | -4.45% | 12.21% | 12.18% | -234.64% | -24.41% | -8.42% | 6.12% | 676.34 Cr |
| Wanbury Ltd. | N/A | 4.15% | -51.05% | N/A | 13.31% | 10.18% | N/A | -45.50% | N/A | 5.09% | 803.76 Cr |
| Ind-Swift Laboratories Ltd. | 1176.61% | -56.15% | -62.18% | 12.63% | 90.50% | 18.55% | 49.25% | -59.15% | 5.23% | 44.59% | 801.38 Cr |
| Sudarshan Pharma Industries Ltd. | 31.33% | 8.95% | -47.90% | 6.55% | 7.29% | 4.03% | -33.33% | 37.50% | 2.29% | 3.16% | N/A |
| Syncom Formulations (India) Ltd. | 18.96% | 76.55% | -40.40% | 19.43% | 15.39% | 15.75% | 12.50% | 67.65% | 13.64% | 10.63% | 1,283.1 Cr |
| Fredun Pharmaceuticals Ltd. | N/A | N/A | N/A | 15.37% | 12.03% | N/A | N/A | N/A | 6.49% | 4.33% | N/A |
| Senores Pharmaceuticals Ltd. | 60.75% | 85.65% | 204.04% | 33.95% | 27.36% | 31.45% | 66.84% | 17.92% | 18.62% | 14.65% | 3,800.8 Cr |
| Kwality Pharmaceuticals Ltd. | 23.34% | 20.52% | -56.71% | 23.64% | 22.23% | 23.26% | 66.87% | 68.54% | 12.71% | 10.75% | N/A |
| Beta Drugs Ltd. | N/A | 22.54% | -41.80% | N/A | 19.84% | 22.28% | N/A | 10.87% | N/A | 11.71% | N/A |
| Bharat Parenterals Ltd. | -9.79% | 32.26% | -45.65% | 6.75% | 4.21% | 10.42% | 48.15% | -367.20% | -13.31% | -12.83% | N/A |
| Mangalam Drugs And Organics Ltd. | -38.03% | -13.66% | N/A | -5.67% | 11.41% | N/A | -372.94% | 174.17% | -14.83% | 2.11% | 56.57 Cr |
| Hester Biosciences Ltd. | -15.20% | 2.15% | 9.80% | 33.25% | 22.20% | 22.17% | 70.89% | 36.21% | 20.19% | 9.27% | 1,284.11 Cr |
| Kilitch Drugs (India) Ltd. | 3.05% | 28.47% | -44.21% | 23.92% | 21.49% | 18.35% | -7.28% | 81.03% | 16.43% | 12.58% | 576.47 Cr |
| Parnax Lab Ltd. | 29.44% | -0.52% | -89.52% | 13.91% | 15.15% | 14.08% | 6.06% | 19.93% | 5.79% | 6.15% | N/A |
| Sakar Healthcare Ltd. | 34.56% | 15.80% | -48.26% | 21.84% | 28.66% | 28.09% | -6.45% | 41.31% | 7.89% | 9.86% | 959.87 Cr |
| Natural Capsules Ltd. | 11.11% | 8.87% | -49.96% | -1.58% | 10.77% | 15.30% | -1026.67% | -96.47% | -15.26% | 0.36% | N/A |
| Gennex Laboratories Ltd. | 17.74% | 59.03% | -98.69% | 19.23% | 19.47% | 17.24% | 0.00% | 19.40% | 14.02% | 13.14% | N/A |
| Valiant Laboratories Ltd. | 115.10% | -26.74% | N/A | 2.04% | 0.57% | 4.41% | 103.67% | -492.31% | 0.43% | -1.65% | 255.75 Cr |
| Makers Laboratories Ltd. | 15.58% | 15.67% | -54.38% | 7.73% | 15.48% | 8.28% | -101.34% | 219.59% | 2.19% | 9.03% | N/A |
| Vivimed Labs Ltd. | -16.79% | -22.00% | -21.16% | -3.60% | -7.46% | -40.74% | -41.94% | 29.74% | -35.42% | -27.49% | 59.78 Cr |
| Alpa Laboratories Ltd. | 5.29% | 3.41% | -53.56% | 3.12% | 24.99% | 21.63% | -98.63% | 16.60% | 0.43% | 17.34% | 149.39 Cr |
| Shree Ganesh Remedies Ltd. | -6.24% | -13.74% | N/A | 34.00% | 39.54% | 32.97% | -22.33% | -19.61% | 16.35% | 21.24% | N/A |
| Sotac Pharmaceuticals Ltd. | N/A | -6.59% | -49.01% | N/A | 18.08% | 12.23% | N/A | 86.15% | N/A | 9.56% | N/A |
| ANG Lifesciences India Ltd. | -20.77% | -36.45% | -70.30% | 0.78% | -0.28% | 6.28% | -46.41% | -23.78% | -11.31% | -13.37% | N/A |
| Trident Lifeline Ltd. | 102.83% | 94.86% | -26.35% | 27.21% | 26.55% | 24.43% | 58.74% | 85.14% | 16.25% | 12.07% | N/A |
| Brooks Laboratories Ltd. | 12.79% | 3.86% | -55.10% | 36.89% | -8.68% | -9.72% | 279.47% | 51.50% | 34.02% | -12.07% | 179.48 Cr |
| Deccan Health Care Ltd. | 13.68% | 25.66% | -39.06% | 8.02% | 4.21% | 4.97% | 42.31% | -32.50% | 4.27% | 1.54% | N/A |
| Walpar Nutritions Ltd. | N/A | 14.78% | -35.51% | N/A | 8.34% | 9.05% | N/A | 47.62% | N/A | 3.90% | N/A |
| Sanjivani Paranteral Ltd. | -14.53% | N/A | N/A | 15.55% | 16.50% | N/A | -32.14% | N/A | 10.58% | 11.55% | N/A |
| Vivo Bio Tech Ltd. | 8.92% | 2.69% | -55.05% | 42.30% | 54.24% | 47.69% | -87.18% | 180.00% | 6.63% | 15.60% | N/A |
| Concord Drugs Ltd. | -16.92% | 0.73% | -57.50% | 10.68% | 9.17% | 8.99% | 375.00% | -27.66% | 1.87% | 0.74% | N/A |
| Medicamen Organics Ltd. | N/A | N/A | N/A | N/A | 17.50% | N/A | N/A | N/A | N/A | 10.60% | N/A |
| Decipher Labs Ltd. | -26.47% | -36.98% | -67.41% | 3.34% | -26.14% | -9.93% | 101.53% | -203.01% | 0.46% | -22.47% | N/A |
| Suven Life Sciences Ltd. | -64.28% | -43.08% | -61.70% | -8269.10% | -2326.86% | -1368.14% | -53.30% | -52.90% | -8412.41% | -2415.04% | 3,495.94 Cr |
Pharma Sector Summary
Revenue Growth (YoY)
11.63%
Average ROE
N/A
Average ROCE
N/A
EBITDA Margin
28.44%
PAT Margin
15.88%
EBITDA Margin (3Y)
N/A
PAT Margin (3Y)
N/A
Total Companies
69
* Q3 represents quarterly (latest quarter) data comparison
* 1 Y represents yearly comparison
* 3 Y represents 3-year rolling average
* TTM represents Trailing Twelve Months
* CAGR represents Compound Annual Growth Rate over 3 years
* M.Cap represents Market Capitalization
* P/E represents Price to Earnings ratio
* P/S represents Price to Sales ratio
* P/BV represents Price to Book Value ratio
* EV/EBITDA represents Enterprise Value to EBITDA ratio
* ROE represents Return on Equity
* ROCE represents Return on Capital Employed
* ROA represents Return on Assets
* All financial figures are in INR
* N/A indicates data not available or not applicable